Incannex Healthcare Ltd Stock Current Valuation
| IXHL Stock | USD 1.98 0.01 0.51% |
Valuation analysis of Incannex Healthcare helps investors to measure Incannex Healthcare's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value is expected to rise to about 57.5 M this year, although Enterprise Value Over EBITDA will most likely fall to (2.39). Fundamental drivers impacting Incannex Healthcare's valuation include:
Price Book 5.2701 | Enterprise Value 31.5 M | Enterprise Value Ebitda (5.13) | Price Sales 2.9 K | Enterprise Value Revenue 366.7486 |
Overvalued
Today
Please note that Incannex Healthcare's price fluctuation is dangerous at this time. Calculation of the real value of Incannex Healthcare is based on 3 months time horizon. Increasing Incannex Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Incannex stock is determined by what a typical buyer is willing to pay for full or partial control of Incannex Healthcare Ltd. Since Incannex Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Incannex Stock. However, Incannex Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.98 | Real 1.77 | Hype 1.96 | Naive 1.47 |
The intrinsic value of Incannex Healthcare's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Incannex Healthcare's stock price.
Estimating the potential upside or downside of Incannex Healthcare Ltd helps investors to forecast how Incannex stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Incannex Healthcare more accurately as focusing exclusively on Incannex Healthcare's fundamentals will not take into account other important factors: Incannex Healthcare Ltd Company Current Valuation Analysis
Incannex Healthcare's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Incannex Healthcare Current Valuation | 31.54 M |
Most of Incannex Healthcare's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Incannex Healthcare Ltd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Incannex Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Incannex Healthcare is extremely important. It helps to project a fair market value of Incannex Stock properly, considering its historical fundamentals such as Current Valuation. Since Incannex Healthcare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Incannex Healthcare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Incannex Healthcare's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Incannex Healthcare Ltd has a Current Valuation of 31.54 M. This is 99.78% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 99.81% higher than that of the company.
Incannex Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Incannex Healthcare's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Incannex Healthcare could also be used in its relative valuation, which is a method of valuing Incannex Healthcare by comparing valuation metrics of similar companies.Incannex Healthcare is currently under evaluation in current valuation category among its peers.
Incannex Healthcare Current Valuation Drivers
We derive many important indicators used in calculating different scores of Incannex Healthcare from analyzing Incannex Healthcare's financial statements. These drivers represent accounts that assess Incannex Healthcare's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Incannex Healthcare's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 143.0M | 188.0M | 66.6M | 42.4M | 47.7M | 60.1M | |
| Enterprise Value | 140.6M | 181.1M | 40.8M | 20.9M | 42.2M | 57.5M |
Incannex Fundamentals
| Return On Equity | -1.15 | ||||
| Return On Asset | -0.57 | ||||
| Operating Margin | (538.33) % | ||||
| Current Valuation | 31.54 M | ||||
| Shares Outstanding | 17.64 M | ||||
| Shares Owned By Insiders | 25.86 % | ||||
| Shares Owned By Institutions | 4.13 % | ||||
| Number Of Shares Shorted | 49.2 K | ||||
| Price To Book | 5.27 X | ||||
| Price To Sales | 2,896 X | ||||
| Revenue | 12 K | ||||
| Gross Profit | 1.01 M | ||||
| EBITDA | (18.5 M) | ||||
| Net Income | (18.46 M) | ||||
| Cash And Equivalents | 37.5 M | ||||
| Cash Per Share | 0.68 X | ||||
| Total Debt | 373 K | ||||
| Current Ratio | 18.84 X | ||||
| Book Value Per Share | 0.64 X | ||||
| Cash Flow From Operations | (15.85 M) | ||||
| Short Ratio | 1.76 X | ||||
| Earnings Per Share | (1.36) X | ||||
| Beta | 2.21 | ||||
| Market Capitalization | 34.76 M | ||||
| Total Asset | 17.05 M | ||||
| Retained Earnings | (110.67 M) | ||||
| Working Capital | 10.58 M | ||||
| Net Asset | 17.05 M |
About Incannex Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Incannex Healthcare Ltd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Incannex Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Incannex Healthcare Ltd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Incannex Healthcare Piotroski F Score and Incannex Healthcare Altman Z Score analysis. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incannex Healthcare. If investors know Incannex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incannex Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.36) | Revenue Per Share 0.001 | Quarterly Revenue Growth 0.296 | Return On Assets (0.57) | Return On Equity (1.15) |
The market value of Incannex Healthcare is measured differently than its book value, which is the value of Incannex that is recorded on the company's balance sheet. Investors also form their own opinion of Incannex Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Incannex Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incannex Healthcare's market value can be influenced by many factors that don't directly affect Incannex Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incannex Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incannex Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incannex Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.